Literature DB >> 25078910

Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.

Robert P Dickson1, John R Erb-Downward1, Hallie C Prescott1, Fernando J Martinez2, Jeffrey L Curtis3, Vibha N Lama1, Gary B Huffnagle4.   

Abstract

The diagnosis and management of pneumonia are limited by the use of culture-based techniques of microbial identification, which may fail to identify unculturable, fastidious, and metabolically active viable but unculturable bacteria. Novel high-throughput culture-independent techniques hold promise but have not been systematically compared to conventional culture. We analyzed 46 clinically obtained bronchoalveolar lavage (BAL) fluid specimens from symptomatic and asymptomatic lung transplant recipients both by culture (using a clinical microbiology laboratory protocol) and by bacterial 16S rRNA gene pyrosequencing. Bacteria were identified in 44 of 46 (95.7%) BAL fluid specimens by culture-independent sequencing, significantly more than the number of specimens in which bacteria were detected (37 of 46, 80.4%, P ≤ 0.05) or "pathogen" species reported (18 of 46, 39.1%, P ≤ 0.0001) via culture. Identification of bacteria by culture was positively associated with culture-independent indices of infection (total bacterial DNA burden and low bacterial community diversity) (P ≤ 0.01). In BAL fluid specimens with no culture growth, the amount of bacterial DNA was greater than that in reagent and rinse controls, and communities were markedly dominated by select Gammaproteobacteria, notably Escherichia species and Pseudomonas fluorescens. Culture growth above the threshold of 10(4) CFU/ml was correlated with increased bacterial DNA burden (P < 0.01), decreased community diversity (P < 0.05), and increased relative abundance of Pseudomonas aeruginosa (P < 0.001). We present two case studies in which culture-independent techniques identified a respiratory pathogen missed by culture and clarified whether a cultured "oral flora" species represented a state of acute infection. In summary, we found that bacterial culture of BAL fluid is largely effective in discriminating acute infection from its absence and identified some specific limitations of BAL fluid culture in the diagnosis of pneumonia. We report the first correlation of quantitative BAL fluid culture results with culture-independent evidence of infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078910      PMCID: PMC4187760          DOI: 10.1128/JCM.01028-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Effect of starvation and the viable-but-nonculturable state on green fluorescent protein (GFP) fluorescence in GFP-tagged Pseudomonas fluorescens A506.

Authors:  M Lowder; A Unge; N Maraha; J K Jansson; J Swiggett; J D Oliver
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

Review 2.  The viable but nonculturable state in bacteria.

Authors:  James D Oliver
Journal:  J Microbiol       Date:  2005-02       Impact factor: 3.422

3.  Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia.

Authors:  Farah K Bahrani-Mougeot; Bruce J Paster; Shirley Coleman; Sara Barbuto; Michael T Brennan; Jenene Noll; Thomas Kennedy; Philip C Fox; Peter B Lockhart
Journal:  J Clin Microbiol       Date:  2007-02-14       Impact factor: 5.948

4.  Breathing new life into pneumonia diagnostics.

Authors:  David R Murdoch; Katherine L O'Brien; J Anthony G Scott; Ruth A Karron; Niranjan Bhat; Amanda J Driscoll; Maria Deloria Knoll; Orin S Levine
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

Review 5.  Genomics of secondary metabolite production by Pseudomonas spp.

Authors:  Harald Gross; Joyce E Loper
Journal:  Nat Prod Rep       Date:  2009-10-01       Impact factor: 13.423

6.  Deaths: preliminary data for 2011.

Authors:  Donna L Hoyert; Jiaquan Xu
Journal:  Natl Vital Stat Rep       Date:  2012-10-10

7.  Retention of enteropathogenicity by viable but nonculturable Escherichia coli exposed to seawater and sunlight.

Authors:  M Pommepuy; M Butin; A Derrien; M Gourmelon; R R Colwell; M Cormier
Journal:  Appl Environ Microbiol       Date:  1996-12       Impact factor: 4.792

8.  Machine operator's lung. A hypersensitivity pneumonitis disorder associated with exposure to metalworking fluid aerosols.

Authors:  D I Bernstein; Z L Lummus; G Santilli; J Siskosky; I L Bernstein
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

9.  Structure of the 16 S ribosomal RNA of the thermophilic cyanobacterium Chlorogloeopsis HTF ('Mastigocladus laminosus HTF') strain PCC7518, and phylogenetic analysis.

Authors:  A Wilmotte; G Van der Auwera; R De Wachter
Journal:  FEBS Lett       Date:  1993-02-08       Impact factor: 4.124

10.  Lung infection--a public health priority.

Authors:  Joseph P Mizgerd
Journal:  PLoS Med       Date:  2006-01-17       Impact factor: 11.069

View more
  54 in total

Review 1.  Homeostasis and its disruption in the lung microbiome.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

Review 2.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 3.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

Review 4.  Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung.

Authors:  Vineet Indrajit Patel; Jordan Patrick Metcalf
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 5.  The respiratory microbiome in idiopathic pulmonary fibrosis.

Authors:  Richard J Hewitt; Philip L Molyneaux
Journal:  Ann Transl Med       Date:  2017-06

6.  Intraalveolar Catecholamines and the Human Lung Microbiome.

Authors:  Robert P Dickson; John R Erb-Downward; Hallie C Prescott; Fernando J Martinez; Jeffrey L Curtis; Vibha N Lama; Gary B Huffnagle
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

7.  Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography.

Authors:  Robert P Dickson; John R Erb-Downward; Christine M Freeman; Lisa McCloskey; James M Beck; Gary B Huffnagle; Jeffrey L Curtis
Journal:  Ann Am Thorac Soc       Date:  2015-06

Review 8.  Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease.

Authors:  Lindsay J Caverly; Yvonne J Huang; Marc A Sze
Journal:  Chest       Date:  2019-05-30       Impact factor: 9.410

9.  Rethinking pneumonia: A paradigm shift with practical utility.

Authors:  Rishi Chanderraj; Robert P Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

10.  Rapid Pathogen Identification in Bacterial Pneumonia Using Real-Time Metagenomics.

Authors:  Kathryn M Pendleton; John R Erb-Downward; Yuwei Bao; William R Branton; Nicole R Falkowski; Duane W Newton; Gary B Huffnagle; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.